Carla Casulo, MD
@DrCarlaCasulo
Followers
2K
Following
2K
Statuses
590
New Yorker. @YaleIMed, @sloan_kettering. Associate Professor, @UR_Med. @WilmotCancer @WomeninLymphoma. #Lymphoma Tweets my own
Rochester, NY
Joined March 2016
Thank you @JohnPLeonardMD for recognizing our important work in #FL made possible with colleagues from many #LEO centers and @MaurerStats. Honored to make it to number 1! @WomenInLymphoma @WilmotCancer @lymphoma
Presenting #LeonardList #ASH24 top #lymphoma abstracts daily countdown – Number 1 – 1652 – Casulo – Outcomes in early relapse of follicular #lymphoma vs early histologic transformation after first line immunochemotherapy of follicular lymphoma
1
5
24
Congratulations @DrJFriedberg and Dr Herrera on this practice changing work
Amazing collaborations in this successful @theNCI study led by Dr. Herrera. @SWOG @eaonc @COGorg @CDNCancerTrials @ALLIANCE_org Inclusive study enrolling pts aged 12+ with remarkable efficacy across all analyzed subgroups. Best-ever reported US results.
0
0
12
How I Treat Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Blood | American Society of Hematology - a great review by @DWallaceMD @MelissaLoh21 and I @WilmotCancer @WomenInLymphoma
1
19
59
RT @WomenInLymphoma: 🩺Join us this Wednesday for #WiLingWednesdays free educational webinar #HodgkinLymphoma
@LisaRoth_MD 🇺🇸 @NicoleWongDo…
0
4
0
RT @WomenInLymphoma: ⚕️Please join us THIS WEDNESDAY May 29 (4pm EDT) 🌎global panel discussion #HodgkinLymphoma
@sairah__ahmed🇺🇸 @DrKellyD…
0
3
0
RT @DrJFriedberg: Congratulations @DrCarlaCasulo on winning RBJ Women of Excellence award tonight! So deserved; in honor of your commitment…
0
5
0
No evidence of benefit with vitamin d supplementation in indolent lymphoma, and important question addressed by @DrJFriedberg @WilmotCancer #ASH2023
0
8
34
RT @DrJFriedberg: BV with DTIC or nivo induction in older patients with HL: long follow-up demonstrates some likely cures. @BloodJournal h…
0
6
0
RT @chanyooncheah: #ASH23 @DrJFriedberg et al Ilyad study: RCT of vitamin D supplementation vs placebo in low tumor burden indolent lymphom…
0
7
0
RT @JudithTrotman1: Mapping the metrics #WiL improve the metrics! Today @WomenInLymphoma co-authors @DrElizaHawkes @DrCarlaCasulo @SoniSmi…
0
20
0
RT @JudithTrotman1: Career development: A balance of opportunities and choices A wonderful perspective from three l…
0
6
0
RT @JudithTrotman1: So many #changechampions @icmlugano committed to productive diversity in #lymphoma care, teaching and research. Such a…
0
9
0
RT @RahulBanerjeeMD: I continue to be so amazingly grateful to the amazing #WoMMen in #MMsm who’ve mentored me so much (@ninashah33 @SandyW…
0
3
0
RT @Dr_AmerZeidan: This is a must read! This quote from the editorial makes me really sad & disappointed as it alludes to the main reason o…
0
18
0
RT @tvoorheesmd: Amazing week with LRF LSRMP at Lake Las Vegas. Great protocol development. Meeting mentors and colleagues was invaluable!…
0
4
0
RT @tobyeyre82: Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
0
13
0
RT @DrJFriedberg: Glad to see ODAC strongly support Pola-R-CHP for patients with newly diagnosed DLBCL with vote of 11-2. Eager for FDA app…
0
3
0